Pericardial disease in patients treated with immune checkpoint inhibitors

BACKGROUND: There are limited data on the occurrence, associations and outcomes of pericardial effusions and pericarditis on or after treatment with immune checkpoint inhibitors (ICIs). METHODS: This was a retrospective study at a single academic center that compared 2842 consecutive patients who re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Jingyi, Drobni, Zsofia Dora, Zafar, Amna, Quinaglia, Thiago, Hartmann, Sarah, Gilman, Hannah K, Raghu, Vineet K, Gongora, Carlos, Sise, Meghan E, Alvi, Raza M, Zubiri, Leyre, Nohria, Anju, Sullivan, Ryan, Reynolds, Kerry L, Zlotoff, Daniel, Neilan, Tomas G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215235/
https://www.ncbi.nlm.nih.gov/pubmed/34145031
http://dx.doi.org/10.1136/jitc-2021-002771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215235/
https://www.ncbi.nlm.nih.gov/pubmed/34145031
http://dx.doi.org/10.1136/jitc-2021-002771

Ejemplares similares